Literature DB >> 2592674

A prospective study of stressful life events and schizophrenic relapse.

J Ventura, K H Nuechterlein, D Lukoff, J P Hardesty.   

Abstract

In this prospective, longitudinal study, 11 recent-onset schizophrenic outpatients who met criteria for psychotic relapse or significant psychotic exacerbation during a 1-year period of standardized maintenance medication, and 19 patients who did not relapse during this follow-up period, were interviewed monthly regarding life events. As hypothesized, for relapsing patients, a significantly higher number of independent life events (those not the result of symptomatology or personal influence) occurred in the month preceding relapse. This increase was apparent relative to either the analogous month of a "nonrelapse" period in the same patient or the average number of independent events per month during a 1-year standardized medication period for nonrelapsing patients. The methodological advances of this design as well as the consistency of these findings with those of previous retrospective studies supports the hypothesis that life events may sometimes "trigger" schizophrenic episodes.

Entities:  

Mesh:

Year:  1989        PMID: 2592674     DOI: 10.1037//0021-843x.98.4.407

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  30 in total

1.  Could stress cause psychosis in individuals vulnerable to schizophrenia?

Authors:  Cheryl Corcoran; Lilianne Mujica-Parodi; Scott Yale; David Leitman; Dolores Malaspina
Journal:  CNS Spectr       Date:  2002-01       Impact factor: 3.790

Review 2.  A new look at the neural diathesis--stress model of schizophrenia: the primacy of social-evaluative and uncontrollable situations.

Authors:  Simon R Jones; Charles Fernyhough
Journal:  Schizophr Bull       Date:  2006-11-14       Impact factor: 9.306

3.  Chronic stress alters neural activity in medial prefrontal cortex during retrieval of extinction.

Authors:  A A Wilber; A G Walker; C J Southwood; M R Farrell; G L Lin; G V Rebec; C L Wellman
Journal:  Neuroscience       Date:  2010-10-31       Impact factor: 3.590

4.  Ambulatory and challenge-associated heart rate variability measures predict cardiac responses to real-world acute emotional stress.

Authors:  Gülce N Dikecligil; Lilianne R Mujica-Parodi
Journal:  Biol Psychiatry       Date:  2010-03-17       Impact factor: 13.382

5.  Chronic Stress Increases Prefrontal Inhibition: A Mechanism for Stress-Induced Prefrontal Dysfunction.

Authors:  Jessica M McKlveen; Rachel L Morano; Maureen Fitzgerald; Sandra Zoubovsky; Sarah N Cassella; Jessie R Scheimann; Sriparna Ghosal; Parinaz Mahbod; Benjamin A Packard; Brent Myers; Mark L Baccei; James P Herman
Journal:  Biol Psychiatry       Date:  2016-03-28       Impact factor: 13.382

6.  Caregivers' stresses when living together or apart from patients with chronic schizophrenia.

Authors:  Tannis M Laidlaw; John H Coverdale; Ian R H Falloon; Robert R Kydd
Journal:  Community Ment Health J       Date:  2002-08

7.  Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8 years later.

Authors:  Joseph Ventura; Kenneth L Subotnik; Michael J Gitlin; Denise Gretchen-Doorly; Arielle Ered; Kathleen F Villa; Gerhard S Hellemann; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2014-12-08       Impact factor: 4.939

8.  Differential effects of homotypic vs. heterotypic chronic stress regimens on microglial activation in the prefrontal cortex.

Authors:  Brittany L Kopp; Dayna Wick; James P Herman
Journal:  Physiol Behav       Date:  2013-05-23

9.  Chronic stress effects on dendritic morphology in medial prefrontal cortex: sex differences and estrogen dependence.

Authors:  J E Garrett; C L Wellman
Journal:  Neuroscience       Date:  2009-05-03       Impact factor: 3.590

10.  Schizophrenia and bipolar disorder are distinguished mainly by differences in neurodevelopment.

Authors:  Jenny Walker; Vivienne Curtis; Philip Shaw; Robin M. Murray
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.